INFECTIOUS DISEASES / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The association between serum 25-hydroxyvitamin D levels and Clostridioides difficile-induced enteritis (CDE) is ambiguous. This study investigated the association and potential causal relationship between serum 25-hydroxyvitamin D levels and the risk of CDE.

Material and methods:
In this real-world observational study, a total of 1898 participants, including 103 patients with CDE and 1795 non-CDE controls, were selected from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Logistic regression and restricted cubic spline (RCS) analyses were used to evaluate the association between serum 25-hydroxyvitamin D levels and the risk of CDE. To assess the potential causal relationship between the two factors, two-sample Mendelian randomization (MR) analysis was performed.

Results:
After adjustments were made for multiple confounders, a high serum 25-hydroxyvitamin D level (odds ratio [OR] = 0.9764; 95% confidence interval [CI], 0.9585–0.9932; p = 0.008) was independently associated with a lower risk of CDE. Similarly, the RCS model demonstrated a linear inverse correlation between serum 25-hydroxyvitamin D levels and the risk of CDE (p for non-linear = 0.165). Furthermore, MR analysis showed that genetically predicted serum 25-hydroxyvitamin D levels were associated with a decreased risk of CDE (IVW: OR = 0.4630; 95% CI: 0.2836–0.7559; p = 0.002). Sensitivity analysis did not show evidence of potential heterogeneity or horizontal pleiotropy.

Conclusions:
This study suggests that low serum 25-hydroxyvitamin D levels are associated with an increased risk of CDE, and this relationship is potentially causal.
REFERENCES (33)
1.
Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis 2012; 55: S65-70.
 
2.
Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008; 46: S12-8.
 
3.
Finn E, Andersson FL, Madin-Warburton M. Burden of Clostridioides difficile infection (CDI) – a systematic review of the epidemiology of primary and recurrent CDI. BMC Infect Dis 2021; 21: 456.
 
4.
Wenisch JM, Schmid D, Tucek G, et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection. 2021; 40: 479-84.
 
5.
Bella SD, Sanson G, Monticelli J, et al. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. Clin Microbiol Rev 2024; 37: e0013523.
 
6.
Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004; 80: 1717S-20S.
 
7.
Hewison M. Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 2010; 321: 103-11.
 
8.
Youssef DA, Miller CW, El-Abbassi AM, et al. Antimicrobial implications of vitamin D. Dermatoendocrinol 2011; 3: 220-9.
 
9.
Furuya-Kanamori L, Wangdi K, Yakob L, et al. 25-hydroxyvitamin D concentrations and Clostridium difficile infection: a meta-analysis. JPEN J Parenter Enteral Nutr 2017; 41: 890-95.
 
10.
Johnson A, Bulgarelli L, Pollard T, et al. MIMIC-IV (Version 1.0). PhysioNet. 2021; doi:10.13026/s6n6-xd98.
 
11.
Smith GD, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014; 23: R89-98.
 
12.
Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA 2017; 318: 1925-6.
 
13.
Harell Jr FEH, Lee KL, Pollock BG. Regression models in clinical studies:determining relationships between predictors and response. J Natl Cancer Inst 1988; 80: 1198-202.
 
14.
Hemani G, Zheng J, Elsworth B, et al. The MR-based platform supports systematic causal inference across the human phenomenon. Elife 2018; 7: e34408.
 
15.
Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 2011; 40: 755-64.
 
16.
Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013; 37: 658-65.
 
17.
Hemani G, Tilling K, Davey SG. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 2017; 13: e1007081.
 
18.
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-egger method. Eur J Epidemiol 2017; 32: 377-89.
 
19.
Greco MF, Minelli C, Sheehan NA, et al. Detecting pleiotropy in Mendelian randomization studies with summary data and a continuous outcome. Stat Med 2015; 34: 2926-40.
 
20.
Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50: 693-8.
 
21.
Buffet-Bataillon S, Tattevin P, Senechal H, et al. Clostridium difficile O27 colitis: hospital-onset but community-acquired. Eur J Clin Microbiol Infect Dis 2012; 31: 2263-7.
 
22.
Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 2020; 74: 1498-513.
 
23.
Gunes N, Çam H. An observational study of serum vitamin D status in critically ill children admitted to the pediatric intensive care unit. Arch Med Sci 2025; 21: 471-7.
 
24.
Maretzke F, Bechthold A, Egert S, et al. Role of vitamin D in preventing and treating selected extraskeletal diseases – an umbrella review. Nutrients 2020; 12: 969.
 
25.
Ananthakrishnan AN, Cagan A, Gainer VS, et al. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39: 1136-42.
 
26.
Sahay T, Ananthakrishnan AN. Vitamin D deficiency is associated with community-acquired Clostridium difficile infection: a case-control study. BMC Infect Dis 2014; 14: 661.
 
27.
Quraishi SA, Litonjua AA, Moromizato T, et al. Association between prehospital vitamin D status and hospital-acquired Clostridium difficile infections. JPEN J Parenter Enteral Nutr 2015; 39: 47-55.
 
28.
Furuya KL, Wangdi K, Yakob L, et al. 25-hydroxyvitamin D concentrations and clostridium difficile infection: a meta-analysis. J Parenteral Enteral Nutr 2017; 41: 890-5.
 
29.
Pinheiroda SF, Machado MC. Antimicrobial peptides: clinical relevance and therapeutic implications. Peptides 2012; 36: 308-14.
 
30.
Vora P, Youdim A, Thomas LS, et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol 2004; 173: 5398-405.
 
31.
Akimbekov NS, Digel I, Sherelkhan DK, et al. Vitamin D and the host-gut microbiome: a brief overview. Acta Histochem Cytochem 2020; 53: 33-42.
 
32.
Khrais A, Mathew AG, Kahlam A, et al. Investigating the correlation between Clostridioides difficile infection and vitamin D deficiency. Cureus 2023; 15: e39970.
 
33.
Tulk S, Hitota S, MacDonald J, et al. Vitamin D downregulates NLRP3 and protects against Clostridium difficile toxin-induced cell death. Abstract presented at Canadian Digestive Diseases Week 2012; February 24-27, 2012; Montreal, Quebec.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top